Abnormal cardiac function in fetuses with increased nuchal translucency

Ultrasound in Obstetrics and Gynecology

Volumn 21, Issue 6, 2003, Pages 539-542

  Rizzo, G ^a,c   Muscatello, A ^a   Angelini, E ^a   Capponi, A ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Ospedale GB Grassi Ostia Roma   (Italy)

^c EUROPEAN HOSPITAL   (Italy)

Author keywords

Diastolic function; Fetal echocardiography; Fetal heart; Nuchal translucency

Indexed keywords

A WAVE; ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETER; FETUS; FETUS ECHOGRAPHY; GESTATION PERIOD; HEART ATRIOVENTRICULAR VALVE; HEART FUNCTION; HEART MUSCLE POTENTIAL; HEART VENTRICLE CONTRACTION; HUMAN; MITRAL VALVE; PRIORITY JOURNAL; TRICUSPID VALVE;

BLOOD FLOW VELOCITY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FETAL DISEASES; FETAL HEART; GESTATIONAL AGE; HEART DISEASES; HUMANS; MATERNAL AGE; MITRAL VALVE; NECK; PARITY; PREGNANCY; TRICUSPID VALVE; ULTRASONOGRAPHY, PRENATAL; VENTRICULAR DYSFUNCTION;

EID: 0037974642     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.137     Document Type: Article

References (19)

1. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk for trisomy 21 by maternal age and fetal nuchal translucency thickness at 11-14 weeks of gestation. Lancet 1999; 18: 519-521.
2. Pajkrt E, van Lith JMM, Mol BWJ, Blecker OP, Bilardo CM. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population. Ultrasound Obstet Gynecol 1998; 12: 163-169.
3. Zoppi MA, Ibba RM, Floris M, Monni G. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia. Ultrasound Obstet Gynecol 2001; 18: 649-651.
4. Montenegro N, Matias A, Areias JC, Castedo S, Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10: 265-268.
5. Hecher K. Assessment of ductus venosus flow during the first and early second trimesters: what can we expect (Opinion). Ultrasound Obstet Gynecol 2001; 17: 285-287.
6. Rizzo G, Arduini D, Romanini C. Doppler echocardiographic assessment of fetal cardiac function. Ultrasound Obstet Gynecol 1992; 2: 434-445.
7. Pacileo G, Paladini D, Pisacane C, Palmieri S, Russo MG, Calabrò R. Role of changing loading condition on atrioventricular flow velocity patterns in normal human fetuses. Am J Cardiol 1994; 73: 891-893.
8. Simpson JM, Sharland GK. Nuchal translucency and congenital heart defects: heart failure or not? Ultrasound Obstet Gynecol 2000; 16: 30-36.
9. Rizzo G, Arduini D, Romanini C, Mancuso S. Doppler echocardiographic assessment of atrioventricular velocity waveforms in healthy and growth retarded fetuses. Br J Obstet Gynaecol 1988; 95: 65-69.
10. Romero T, Covell J, Friedman WF. A comparison of pressure-volume relations of the fetal, newborn and adult heart. Am J Physiol 1972; 222: 1285-1290.
11. Miki S, Murakami T, Iwase T, Tomita T, Nakamura Y, Kawai C. Doppler echocardiographic transmitral peak early velocity does not directly reflect thermodynamic changes in human; importance of normalization to mitral stroke volume. J Am Coll Cardiol 1991; 17: 1507-1516.
12. Von Kaisenberg CS, Brand Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol 1998; 91: 319-323.
13. Chitayat D, Kalousek DK, Bamforth JS. Lymphatic abnormalities in fetuses with posterior cervical cystic hygroma. Am J Med Genet 1989; 33: 352-356.
14. Sebire NJ, Snijders RJ, Davenport M, Greenough A, Nicolaides KH. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia. Obstet Gynecol 1997; 90: 943-946.
15. Lam YH, Tang MH, Lee CP, Tse HY. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation. Ultrasound Obstet Gynecol 1999; 13: 238-240.
16. Hyett JA, Moscoso G, Nicolaides KH. Increased nuchal translucency in trisomy 21 fetuses: relation to narrowing of the aortic isthmus. Hum Reprod 1995; 10: 3045-3048.
17. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides K. Screening for chromosomal abnormalities at 11-14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998; 12: 380-384.
18. Bilardo CM, Muller MA, Zikulnig L, Schipper M, Hecher K. Ductus venosus studies in fetuses at risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001; 17: 288-294.
19. Antolin E, Comas C, Torrents M, Munoz A, Figueras F, Echevarria M, Cararach M, Carrera JM. The role of ductus venosus blood flow assessment in screening for chromosomal anomalies at 10-16 weeks of gestation. Ultrasound Obstet Gynecol 2001; 17: 295-300.